MA
BLCM

MUFG Americas’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

MUFG Americas’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-9
Closed -$1K – 1037
2017
Q4 		$1K Sell
9
-6
-40% -$588 ﹤0.01% 1034
2017
Q3 		$2K Hold
15
– – ﹤0.01% 1067
2017
Q2 		$2K Buy
15
+7
+88% +$869 ﹤0.01% 1081
2017
Q1 		$1K Hold
8
– – ﹤0.01% 1114
2016
Q4 		$1K Sell
8
-9
-53% -$1.6K ﹤0.01% 1078
2016
Q3 		$3K Sell
17
-9
-35% -$1.55K ﹤0.01% 1062
2016
Q2 		$3K Hold
26
– – ﹤0.01% 1080
2016
Q1 		$2K Sell
26
-18
-41% -$1.96K ﹤0.01% 1118
2015
Q4 		$9K Buy
+44
New +$7.87K ﹤0.01% 856

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MUFG Americas's BLCM Position: Q1 2018 in Review

MUFG Americas sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2018, closing a stake of 9 shares — an estimated $1K sold.

MUFG Americas first reported a position in BLCM in Q4 2015 and held it in 9 quarters. The position peaked at $9K in Q4 2015. 90 funds tracked by Wall St. Rank hold BLCM as of Q1 2018.

  • MUFG Americas reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • MUFG Americas sold 9 Bellicum Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1K.
  • MUFG Americas first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2015 and held it in 9 quarters.
  • MUFG Americas's Bellicum Pharmaceuticals, Inc. position peaked at $9K in Q4 2015.
  • 90 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2018.

Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.